Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,728,263
+$42,716 QoQ
Shares Held
6,868
-11.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
5.01%
of 13F equity value
Holder Rank
#2,085
of 4,153 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stegent Equity Advisors, Inc. holds $2,590,515 across 4 Drug Manufacturers - General names. ABBV ranks #1 (66.7% of the industry book) .
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,728,263 | 6,868 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,685,547 | 7,750 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,497,167 | 10,929 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $817,104 | 3,529 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,484,960 | 8,000 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $934,878 | 4,462 | Shares | Sole | 2025-05-01 | |
| 2024-06-30 | $328,803 | 1,917 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,015,389 | 5,576 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $247,797 | 1,599 | Shares | Sole | 2024-02-05 | |
| No filing history on record for this holder in this stock. | ||||||